Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Applications
  3. inflammatory bowel disease
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Videos

Refine by
Locations

  • USA
  • Europe
  • North America
Industries served

  • Medical / Health Care

Inflammatory Bowel Disease Product Applications

4 applications found

Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease

Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease

A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet need, including inflammatory bowel disease, chemotherapy-induced gut injury, food allergies, and celiac disease. ...

ByKallyope Inc.  based in  New York City, NEW YORK (USA)


Medical diagnostics solutions for inflammatory bowel disease sector

Medical diagnostics solutions for inflammatory bowel disease sector

Inflammatory bowel disease (IBD), largely comprising the two conditions, Crohn’s Disease and Ulcerative Colitis, is now emerging as a global health problem. ...

ByDiagNodus Ltd.  based in  Cambridge, UNITED KINGDOM


Microscope System for Molecular imaging of cancer

Microscope System for Molecular imaging of cancer

Longitudinal imaging of pancreatic cancer. Monitor in a minimally invasive manner both tissue morphology and fibrosis (fluorescein) and cathepsin activity (Prosense® 680). A very thin probe (S 650) was used to monitor the pancreas of the same mouse over 9 months. ...

ByMauna Kea Technologies  based in  Paris, FRANCE


Microbiome Therapeutics for Clinical Trials

Microbiome Therapeutics for Clinical Trials

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...

ByFinch Therapeutics Group, Inc.  based in  Somerville, MASSACHUSETTS (USA)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT